Detailed Information on Publication Record
2019
Detection of a deletion at 22q11 locus involving ZNF280A/ZNF280B/PRAME/GGTLC2 in B-cell malignancies: simply a consequence of an immunoglobulin lambda light chain rearrangement
MRÁZ, Marek and Šárka POSPÍŠILOVÁBasic information
Original name
Detection of a deletion at 22q11 locus involving ZNF280A/ZNF280B/PRAME/GGTLC2 in B-cell malignancies: simply a consequence of an immunoglobulin lambda light chain rearrangement
Authors
MRÁZ, Marek (203 Czech Republic, guarantor, belonging to the institution) and Šárka POSPÍŠILOVÁ (203 Czech Republic, belonging to the institution)
Edition
British journal of haematology, England, Wiley-Blackwell, 2019, 0007-1048
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30205 Hematology
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 5.518
RIV identification code
RIV/00216224:14740/19:00108506
Organization unit
Central European Institute of Technology
UT WoS
000478608100010
Keywords in English
array CGH; chronic lymphocytic leukaemia; loss of 22q11; lambda light chain; deletion
Tags
International impact, Reviewed
Změněno: 26/2/2020 15:29, Mgr. Pavla Foltynová, Ph.D.
Abstract
V originále
In this journal, Mestichelli et al (2018) recently reported that a submicroscopic 22q11 deletion is a potentially significant genomic aberration in chronic lymphocytic leukaemia (CLL), and that this alteration is missed by current routine techniques. This was based on the analysis of 23 CLL cases by oligonucleotide-based array comparative genomic hybridisation (aCGH; CytoChipCancer 4x180K, Illumina). The authors found 4 CLL cases with a deletion located at 22q11 that ranged in size from 0.68 Mb–0.49 Mb. The authors claimed that the minimally deleted region included the ZNF280A, ZNF280B, GGTLC2 and PRAME genes. The deletion in the 22q11 region was originally described by Gunn et al (2009) using aCGH and detected in 28 out of 187 analysed CLL cases.
Links
NV18-03-00054, research and development project |
|